All In MedTech

FDA Clearance Tracker · P930038-S025

ANGIO-SEAL HEMOSTATIC PUNCTURE CLOSURE DEVICE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 17, 2000 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 17, 2000

Approved

Time to decision

62 days

Received May 16, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P930038-S025
Device name
ANGIO-SEAL HEMOSTATIC PUNCTURE CLOSURE DEVICE
Applicant location
Elkton, MD
Received
May 16, 2000
Decided
Jul 17, 2000
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P930038

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code MGB

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MODIFICATION TO THE DEPLOYMENT FORCE SPECIFICATION.

Source documents

Other decisions for Terumo Medical Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.